CRISPR-Cas9脂质纳米颗粒用于向瘤微环境中的循环素依赖激酶
Mohammad Mashreghi1,2, Mahere Rezazade Bazaz1,3, Mahmoud Reza Jaafari1,4
1Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
Biotechnology progress
|January 29, 2026
概括
这项研究开发了CRISPR-Cas9等离子体DNA封装在脂质纳米颗粒中,作为一种新的癌症治疗方法. 这种基因淘汰策略有效地抑制了瘤生长,并在临床前模型中改善了生存率.
科学领域:
- 生物技术是生物技术.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 循环素依赖性激酶4和6 (CDK4/6) 在癌症进展中起着至关重要的作用.
- 向CDK4/6是癌症治疗的一个重要策略.
研究的目的:
- 开发一种新型的癌症治疗方法,使用集定期间隔的短Palindromic重复 (CRISPR) -CRISPR相关蛋白9 (Cas9) 质粒DNA (pDNA) 封装在脂质纳米粒子 (LNP) 中.
- 调查针对CDK4/6的基因淘汰策略在癌症治疗中的有效性.
主要方法:
- 使用微流体系统准备和表征pDNA-LNP配方.
- 用Annexin-V-FITC-PI方法评估了细胞毒性和亡诱导.
- 用实时定量PCR (qPCR) 来量化CDK4和CDK6的基因表达水平.
- 在临床前癌症模型中评估了体内抗瘤活性.
主要成果:
- pDNA-LNP的水力动力直径为90.0 ± 0.1 nm,PDI为0.1和负的泽塔电位.
- 在接受治疗的细胞中观察到显著的亡诱导和CDK4/6表达的减少.
- 在体内研究显示瘤大小减少和增加中位生存时间 (MST) 从31到51天与0.5μg的pDNA-LNP.
- 剂量为1μg的pDNA-LNP表明潜在的毒性,需要进一步优化剂量.
结论:
- 在LNP中封装的CRISPR-Cas9pDNA是癌症治疗的一个有希望的策略.
- 这种基因淘汰方法有效抑制瘤生长并提高生存率.
- 需要进行进一步的研究,以优化剂量以确保安全有效的治疗应用.
相关概念视频
CRISPR
57.8K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.8K
The Tumor Microenvironment
7.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.8K
CRISPR and crRNAs
19.1K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
19.1K
CRISPR/Cas9 Genome Editing
1.8K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.8K
cAMP-dependent Protein Kinase Pathways
8.5K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.5K
Protein Kinases and Phosphatases
15.1K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.1K


